Qingqin Tan

588 total citations
14 papers, 440 citations indexed

About

Qingqin Tan is a scholar working on Biomedical Engineering, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Qingqin Tan has authored 14 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Qingqin Tan's work include Nanoplatforms for cancer theranostics (7 papers), CAR-T cell therapy research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Qingqin Tan is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), CAR-T cell therapy research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Qingqin Tan collaborates with scholars based in China, Hong Kong and Macao. Qingqin Tan's co-authors include Xi Huang, Tianchuan Zhu, Zhaoyan Zhao, Hong Shan, Ben Zhong Tang, Yuchen Xiao, Lantian Tang, Guanmin Jiang, Yuhui Liao and Wei Wang and has published in prestigious journals such as ACS Nano, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Qingqin Tan

13 papers receiving 437 citations

Peers

Qingqin Tan
Qingqin Tan
Citations per year, relative to Qingqin Tan Qingqin Tan (= 1×) peers Zhaoyan Zhao

Countries citing papers authored by Qingqin Tan

Since Specialization
Citations

This map shows the geographic impact of Qingqin Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqin Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqin Tan more than expected).

Fields of papers citing papers by Qingqin Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqin Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqin Tan. The network helps show where Qingqin Tan may publish in the future.

Co-authorship network of co-authors of Qingqin Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqin Tan. A scholar is included among the top collaborators of Qingqin Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqin Tan. Qingqin Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Tan, Qingqin, Yuqian Yan, Qi Chen, et al.. (2025). Overcoming barriers in glioblastoma: The potential of CAR T cell immunotherapy. Theranostics. 15(14). 7090–7126. 2 indexed citations
3.
Zhang, Lan, et al.. (2024). Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy. Journal of Nanobiotechnology. 22(1). 510–510. 20 indexed citations
4.
Tan, Qingqin, et al.. (2023). Functionalized Rhodium Nanoparticles as Antimicrobial Agents for Treatment of Drug‐Resistant Skin and Soft Tissue Infections. Advanced Healthcare Materials. 12(19). e2203200–e2203200. 5 indexed citations
6.
Li, Bin, Dong Wang, Michelle M. S. Lee, et al.. (2021). Fabrics Attached with Highly Efficient Aggregation-Induced Emission Photosensitizer: Toward Self-Antiviral Personal Protective Equipment. ACS Nano. 15(8). 13857–13870. 55 indexed citations
7.
8.
Tan, Qingqin, Lingjie He, Xiaojun Meng, et al.. (2021). Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. Journal of Nanobiotechnology. 19(1). 173–173. 68 indexed citations
9.
Zhu, Tianchuan, Yuchen Xiao, Xiaojun Meng, et al.. (2021). Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19. Journal of Nanobiotechnology. 19(1). 391–391. 24 indexed citations
10.
Zhao, Zhaoyan, Yuchen Xiao, Lingqing Xu, et al.. (2021). Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment. ACS Applied Materials & Interfaces. 13(18). 20995–21006. 105 indexed citations
11.
Liao, Yuhui, Bin Li, Zheng Zhao, et al.. (2020). Targeted Theranostics for Tuberculosis: A Rifampicin-Loaded Aggregation-Induced Emission Carrier for Granulomas Tracking and Anti-Infection. ACS Nano. 14(7). 8046–8058. 46 indexed citations
12.
Li, Bin, et al.. (2020). Next‐generation Theranostics: Functionalized Nanomaterials Enable Efficient Diagnosis and Therapy of Tuberculosis. Advanced Therapeutics. 3(9). 14 indexed citations
13.
Zhao, Zhaoyan, Qingqin Tan, Xiaoxia Zhan, et al.. (2018). Cascaded Electrochemiluminescence Signal Amplifier for the Detection of Telomerase Activity from Tumor Cells and Tissues. Theranostics. 8(20). 5625–5633. 12 indexed citations
14.
Liao, Yuhui, Zhijin Fan, Huaping Deng, et al.. (2018). Zika Virus Liquid Biopsy: A Dendritic Ru(bpy)32+-Polymer-Amplified ECL Diagnosis Strategy Using a Drop of Blood. ACS Central Science. 4(10). 1403–1411. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026